IA
LRMR icon

IFP Advisors’s Larimar Therapeutics LRMR Stock Holding History

IFP Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7K Buy
1,213
+1,058
+683% +$4.2K ﹤0.01% 3956
2026
Q1 		$698 Sell
155
-60
-28% -$240 ﹤0.01% 4338
2025
Q4 		$819 Buy
215
+42
+24% +$163 ﹤0.01% 4135
2025
Q3 		$559 Buy
173
+88
+104% +$330 ﹤0.01% 4139
2025
Q2 		$246 Buy
+85
New +$197 ﹤0.01% 4594
2025
Q1 		– Sell
-4
Closed -$15 – 4514
2024
Q4 		$15 Buy
+4
New +$26 ﹤0.01% 4492
2019
Q1 		$1K Hold
17
– – ﹤0.01% 2230
2018
Q4 		$1K Hold
17
– – ﹤0.01% 3340
2018
Q3 		$2K Hold
17
– – ﹤0.01% 3552
2018
Q2 		$2K Hold
17
– – ﹤0.01% 3597
2018
Q1 		$1K Hold
17
– – ﹤0.01% 3645
2017
Q4 		$1K Hold
17
– – ﹤0.01% 3696
2017
Q3 		$1K Hold
17
– – ﹤0.01% 3923
2017
Q2 		$1K Hold
17
– – ﹤0.01% 3906
2017
Q1 		$1K Hold
17
– – ﹤0.01% 3825
2016
Q4 		$1K Hold
17
– – ﹤0.01% 3804
2016
Q3 		$1K Hold
17
– – ﹤0.01% 3747
2016
Q2 		$1K Hold
17
– – ﹤0.01% 3645
2016
Q1 		$1K Hold
17
– – ﹤0.01% 2219
2015
Q4 		$1K Buy
+17
New +$2.73K ﹤0.01% 3533

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

IFP Advisors's LRMR Position: Q2 2026 in Review

IFP Advisors increased its Larimar Therapeutics (LRMR) stake by 683% in Q2 2026, buying an estimated $4.2K and bringing the position to 1,213 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3956.

IFP Advisors first reported a position in LRMR in Q4 2015 and has held it in 20 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • IFP Advisors held 1,213 shares of Larimar Therapeutics worth $3.7K as of Q2 2026.
  • IFP Advisors bought 1,058 Larimar Therapeutics shares in Q2 2026, an estimated $4.2K.
  • Larimar Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3956 holding.
  • IFP Advisors first reported a position in Larimar Therapeutics in Q4 2015 and has held it in 20 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.